T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease, involving neuroinflammation and T cell infiltration in the central nervous system. However, the contribution of T cell responses to the pathology of the disease is not fully understood. Here we show, by flow cytometric analysi...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 13; no. 1; pp. 6733 - 13
Main Authors Yazdani, Solmaz, Seitz, Christina, Cui, Can, Lovik, Anikó, Pan, Lu, Piehl, Fredrik, Pawitan, Yudi, Kläppe, Ulf, Press, Rayomand, Samuelsson, Kristin, Yin, Li, Vu, Trung Nghia, Joly, Anne-Laure, Westerberg, Lisa S, Evertsson, Björn, Ingre, Caroline, Andersson, John, Fang, Fang
Format Journal Article
LanguageEnglish
Published England Nature Publishing Group 08.11.2022
Nature Publishing Group UK
Nature Portfolio
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease, involving neuroinflammation and T cell infiltration in the central nervous system. However, the contribution of T cell responses to the pathology of the disease is not fully understood. Here we show, by flow cytometric analysis of blood and cerebrospinal fluid (CSF) samples of a cohort of 89 newly diagnosed ALS patients in Stockholm, Sweden, that T cell phenotypes at the time of diagnosis are good predictors of disease outcome. High frequency of CD4 FOXP3 effector T cells in blood and CSF is associated with poor survival, whereas high frequency of activated regulatory T (Treg) cells and high ratio between activated and resting Treg cells in blood are associated with better survival. Besides survival, phenotypic profiling of T cells could also predict disease progression rate. Single cell transcriptomics analysis of CSF samples shows clonally expanded CD4 and CD8 T cells in CSF, with characteristic gene expression patterns. In summary, T cell responses associate with and likely contribute to disease progression in ALS, supporting modulation of adaptive immunity as a viable therapeutic option.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2041-1723
2041-1723
DOI:10.1038/s41467-022-34526-9